An experimental form of PET imaging may potentially enable the diagnosis of chronic traumatic encephalopathy in live subjects at some point in the future, according to a new study. {read more here}

In retrospective research, 68Ga-PSMA-11 has provided unprecedented accuracy for localizing recurrent prostate cancer, Dr. Thomas A. Hope of the University of California, San Francisco, and colleagues note in JAMA Oncology, online March 28. {read more here}

“The results of this study provide initial support for the flortaucipir PET scan to detect abnormal tau from CTE during life,” said lead author Robert Stern, professor of neurology, neurosurgery, and anatomy and neurobiology at the Boston University School of Medicine. {read more here}

The new tool was created by taking a molecular probe used in positron emission tomography (PET) scanning for Alzheimer’s or other tau-related diseases and modifying ¬it for a new purpose. The probe, called T807, binds specifically to the abnormal tau protein. When the probe is tagged with a radioactive isotope, its binding to abnormal tau can be detected by a PET scanner, indicating the presence of disease. {read more here}